Orphan drugs.
D002210:Caprylates; D002331:Carnitine / Q000172:deficiency / Q000627:therapeutic use; D002614:Chelating Agents / Q000627:therapeutic use; D002769:Cholelithiasis / Q000188:drug therapy; D004345:Drug Industry; D005989:Glycerides / Q000008:administration & dosage; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D009965:Orphan Drug Production; D014266:Trientine / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D002210:Caprylates; D002614:Chelating Agents; D005989:Glycerides; D002331:Carnitine; D014266:Trientine; C025343:monooctanoin